HDAC drugs for Multiple Myeloma
2 tracked HDAC drugs in the Multiple Myeloma race. The class explanation lives on the HDAC page; the full indication pipeline across every mechanism is on the Multiple Myeloma page.
1 Phase 1/21 US approval withdrawn
Head-to-head evidence: Panobinostat vs Purinostat Mesylate